Making medicines more affordable
Understanding the impact of the Inflation Reduction Act (IRA)
The Inflation Reduction Act (IRA) is reshaping the future of healthcare access and affordability in the United States. By targeting high prescription drug costs—particularly those under Medicare—the IRA introduces sweeping reforms aimed at reducing financial burdens for patients and encouraging more sustainable drug pricing in the following ways.
Lower prescription drug costs through negotiation.
Keeping price hikes in check with inflation rates.
Protecting patients through out-of-pocket caps.
Additional support for low-income individuals.
The IRA is a series of overlapping changes to Medicare negotiation, Part D benefit design and manufacturer rebate obligations that hit different products, therapy areas and patient populations on different timelines. What separates the pharma teams navigating this well from the ones behind is the quality of the prescription, patient and payer data they use to model scenarios before they need to react to them.
Symphony Health, a HealthVerity company, has spent more than two decades building the prescription and patient data infrastructure pharma commercial teams rely on for exactly this kind of modeling. Explore the resources below, or request a working session to walk through a specific IRA scenario with our team.
Go deeper on the IRA provisions reshaping pharma strategy
Practical guidance on the three IRA provisions with the most immediate operational impact: negotiation strategy, Part-D cost tracking and benefit redesign:
Navigating the impacts of the Inflation Reduction Act (IRA): Strategic considerations for pharma
TrOOPs: Tracking cost implications under IRA Part D reforms
Subtler scopes: Where IRA drug negotiations meet Part D redesigns
While the full impact remains to be seen, one thing is clear: the pharmaceutical industry is entering a new era of accountability, transparency, and patient affordability.
For more information
Please contact us directly for more information or to speak with an expert.